CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection
NCT06994975
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
890
Enrollment
OTHER
Sponsor class
Conditions
Acute Ischemic Stroke
Interventions
DRUG:
0.25mg/kg TNK
DRUG:
Standard medical treatment
Sponsor
Huashan Hospital